Beijing Chunlizhengda Medical Instruments Co., Ltd. (HKG:1858)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
7.03
-0.10 (-1.33%)
Oct 22, 2026, 4:08 PM HKT

HKG:1858 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
975.271,046805.861,2091,2021,108
Revenue Growth
6.78%29.77%-33.32%0.58%8.43%18.18%
Gross Profit
616.46653.4516.49855.18900.08844.03
Operating Income
285.34270.2791.96261.3281.35344.44
Net Income
278.03272.54124.99277.82307.72322.36
Earnings Per Share
0.720.710.330.720.800.93
EPS Growth
70.98%115.15%-54.17%-10.00%-13.98%13.41%

Revenue by Segment

Fiscal Year
FY 2025FY 2024
Period EndingDec '25 Dec '24
Medical Device Products
1,045805.22
Unallocated Other
0.80.64
Total
1,046805.86

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
2,1262,2201,8862,0981,7251,736
Total Debt
3.063.280.871.751.311.23
Net Cash (Debt)
2,1232,2171,8852,0971,7241,735
Net Cash Growth
6.34%17.64%-10.11%21.64%-0.67%152.17%
Net Cash Per Share
5.495.784.985.434.485.01

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
297.68404.84-1.9511.7141.01164.79
Capital Expenditures
-56.57-59.13-49.17-33.24-24.9-199.41
Free Cash Flow
241.1345.71-51.07478.4716.1-34.62
Free Cash Flow Growth
59.46%--2871.30%--

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
63.21%62.48%64.09%70.76%74.91%76.17%
Operating Margin
29.26%25.84%11.41%21.62%23.41%31.08%
Pretax Margin
31.57%28.85%16.33%25.31%28.04%33.15%
Profit Margin
28.51%26.06%15.51%22.99%25.61%29.09%
FCF Margin
24.72%33.06%-6.34%39.59%1.34%-3.12%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.3040.3600.1320.3620.3130.130
Dividend Per Share Growth
177.13%172.73%-63.54%15.65%140.77%-
Dividend Yield
4.33%1.75%1.14%1.60%1.46%0.55%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
8.4728.7635.5631.1826.6828.17
Forward PE
7.9819.8210.0212.8914.6711.29
P/FCF Ratio
18.0222.67-18.10509.88-
PS Ratio
4.467.505.527.176.838.20